OrthoPediatrics Corp: stockholders equity
Stockholders equity for OrthoPediatrics Corp. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All OrthoPediatrics Corp financial histories
What this measure means
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
Exact concept: us-gaap:StockholdersEquity. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2014-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 346,596,000 | USD | 2026-03-04 | 10-K · 0001425450-26-000013 |
| At date | 2024-12-31 | 354,566,000 | USD | 2026-03-04 | 10-K · 0001425450-26-000013 |
| At date | 2023-12-31 | 377,025,000 | USD | 2026-03-04 | 10-K · 0001425450-26-000013 |
| At date | 2022-12-31 | 378,648,000 | USD | 2026-03-04 | 10-K · 0001425450-26-000013 |
| At date | 2021-12-31 | 225,369,000 | USD | 2025-03-05 | 10-K · 0001425450-25-000015 |
| At date | 2020-12-31 | 234,768,000 | USD | 2024-03-08 | 10-K · 0001425450-24-000013 |
| At date | 2019-12-31 | 142,361,000 | USD | 2023-03-01 | 10-K · 0001425450-23-000024 |
| At date | 2018-12-31 | 81,732,000 | USD | 2022-03-03 | 10-K · 0001425450-22-000027 |
| At date | 2017-12-31 | 47,495,000 | USD | 2021-03-11 | 10-K · 0001425450-21-000047 |
| At date | 2016-12-31 | -65,309,000 | USD | 2020-03-05 | 10-K · 0001425450-20-000023 |
| At date | 2015-12-31 | -54,112,000 | USD | 2019-03-07 | 10-K · 0001425450-19-000027 |
| At date | 2014-12-31 | -42,653,000 | USD | 2018-03-15 | 10-K · 0001425450-18-000040 |
Related financial histories
- OrthoPediatrics Corp: total assets
- OrthoPediatrics Corp: total liabilities
- OrthoPediatrics Corp: cash and cash equivalents
- OrthoPediatrics Corp: net income or loss
- OrthoPediatrics Corp: operating cash flow
- OrthoPediatrics Corp: capital expenditure payments
- OrthoPediatrics Corp: revenue
- OrthoPediatrics Corp: contract revenue excluding tax
- OrthoPediatrics Corp: financing cash flow
- OrthoPediatrics Corp: investing cash flow
- OrthoPediatrics Corp: retained earnings or deficit
- OrthoPediatrics Corp: basic weighted-average shares
- OrthoPediatrics Corp: diluted weighted-average shares
- OrthoPediatrics Corp: basic earnings per share
- OrthoPediatrics Corp: diluted earnings per share
- OrthoPediatrics Corp: income tax expense or benefit
- OrthoPediatrics Corp: net property, plant and equipment
- OrthoPediatrics Corp: share-based compensation expense
- OrthoPediatrics Corp: operating income or loss
- OrthoPediatrics Corp: current assets
- OrthoPediatrics Corp: interest expense
- OrthoPediatrics Corp: current liabilities
- OrthoPediatrics Corp: current accounts payable
- OrthoPediatrics Corp: goodwill carrying amount
- OrthoPediatrics Corp: net finite-lived intangible assets
- OrthoPediatrics Corp: net current accounts receivable
- OrthoPediatrics Corp: operating expenses
- OrthoPediatrics Corp: net inventory
- OrthoPediatrics Corp: gross profit
- OrthoPediatrics Corp: cost of revenue
- OrthoPediatrics Corp: research and development expense
Inspect the source
- Entity
- OrthoPediatrics Corp / CIK 0001425450
- Captured
- 2026-09-20T08:03:52.240Z
- SEC response SHA-256
b44cec35ab25d49ecee7267ebf0a244054c4578c7e4c5d65f34a2bd8bfc555bc
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001425450.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))